市场调查报告书
商品编码
1402716
南美洲和中美洲智慧生命科学製造市场预测至 2033 年 - 区域分析 - 按组件(解决方案和服务)、技术和应用(製药、生物製药和医疗器材)South & Central America Smart Life Sciences Manufacturing Market Forecast to 2033 - Regional Analysis - by Component (Solutions and Services), Technology, and Application (Pharma, Bio-Pharma, and Medical Device) |
南美洲和中美洲智慧生命科学製造市场预计将从2023年的15.7498亿美元成长到2033年的52.8577亿美元。预计2023年至2033年CAGR为12.9%。
Pharma 4.0 的采用不断增加,推动南美洲和中美洲智慧生命科学製造市场
科技在医疗保健领域一直发挥着重要作用,其中与肿瘤学、神经学和免疫学等其他领域相比,生物技术产业是资料分析领域最新技术进步中受益最大的领域。新兴的资料科学技术也有助于生物技术产业的发展。生物技术实验室的主要作用是生物体分析、新药研究等。
现代资料分析工具使生物技术研究人员能够创建预测分析模型,并最终使他们了解实现其预期目的和目的的最有效方法。大资料、人工智慧、虚拟实境、资料视觉化和资料安全是生物技术实验室常用的技术。 Tableau 帮助 Novozymes 将报表时间缩短了 90% 以上。它还协助公司部门内的策略决策,如销售、原材料采购、规划和财务。此外,Tableau 还允许 Novozymes 的销售人员与客户分享关键见解,从而建立关係并提高收入绩效。
阿斯特捷利康 (AstraZeneca, plc) 是一家英国-瑞典跨国製药和生物技术公司,利用资料和技术来最大限度地缩短发现和交付潜在新药的时间。该公司的研发部门嵌入了资料科学和人工智慧功能,使科学家能够突破科学的界限,提供改变生活的药物。他们将人工智慧应用于从目标识别到临床试验的整个发现和开发过程,以发现指导药物发现和开发过程的新见解。
南美洲和中美洲智慧生命科学製造市场概述
南美洲的智慧生命科学製造市场分为巴西、阿根廷和南美洲其他地区。由于北美国家的积极影响,预计该地区在此期间将温和发展。南美洲预计将针对医疗器材、药品和其他生命科学产品的使用和审批制定监管政策。巴西的医疗器材市场由巴西卫生监管机构 ANVISA 监管。 ANVISA 提出了一项新决议 RDC 687/2022,授予或续展医疗器材巴西良好生产规范 (BGMP) 认证,该决议于 2022 年 6 月 1 日生效,废除 RDC 183/2017。 RDC 183 于 2017 年发布,旨在现代化并加速 GMP 凭证的颁发流程。 RDC 号决议687 于 2022 年 5 月 13 日发布,以简化 GMP 认证所需的文件。它降低了认证的技术要求,这为认证过程提供了巨大动力。此外,美国、加拿大等周边国家的製造商正在向南美洲国家扩张,製造商专注于建造智慧製造设施,从长远来看,这将有帮助。 2022 年 5 月,强生南美公司与 Microsoft 合作,透过在组织中嵌入智慧自动化来实现业务转型。重新构想工作的机会非常重要,并且有可能赋予员工新技能并为其配备新技能;能力;以及专注于充实、有吸引力和目标驱动的工作的自由。因此,所有上述因素预计将在未来几年加速南美智慧生命科学製造市场的成长。
南美洲及中美洲智慧生命科学製造市场收入及 2030 年预测(百万美元)
南美洲和中美洲智慧生命科学製造市场区隔
南美洲和中美洲智慧生命科学製造市场分为技术、组件、应用和国家。
根据组件,南美洲和中美洲智慧生命科学製造市场分为解决方案和服务。 2023年,解决方案领域在南美洲和中美洲智慧生命科学製造市场中占据更大份额。
根据技术领域分为 AR/VR 系统、物联网 (IOT)、人工智慧 (AI)、网路安全、大数据等。 2023年,物联网领域在中南美洲智慧生命科学製造市场中占最大份额。此外,网路安全领域分为IT网路安全和OT网路安全。
根据应用,南美洲和中美洲智慧生命科学製造市场分为製药、生物製药和医疗设备。 2023 年,製药领域在南美洲和中美洲智慧生命科学製造市场中占据最大份额。
依国家划分,南美洲和中美洲智慧生命科学製造市场分为阿根廷、巴西以及南美洲和中美洲其他地区。 2023年,巴西在南美洲和中美洲智慧生命科学製造市场占据主导地位。
ABB Ltd、博世力士乐股份公司、艾默生电气公司、Fortinet Inc、通用电气公司、霍尼韦尔国际公司、国际商业机器公司、罗克韦尔自动化公司、西门子股份公司和Sophos Ltd 是在南美洲和中美洲营运的一些领先公司智慧生命科学製造市场。
The South & Central America Smart Life sciences manufacturing market is expected to grow from US$ 1,574.98 million in 2023 to US$ 5,285.77 million by 2033. It is estimated to grow at a CAGR of 12.9% from 2023 to 2033.
Rising Adoption of Pharma 4.0 Fuel South & Central America Smart Life Sciences Manufacturing Market
Technology has been playing a major role in the healthcare sector, wherein the biotechnology industry is the most benefited segment by recent technological advancements in data analytics, compared to other domains such as oncology, neurology, and immunology. Emerging data sciences technologies also assist in the growth of the biotechnology industry. The analysis of living organisms, research for novel drugs, etc., are the major roles played by biotechnology laboratories.
Modern data analytics tools have allowed biotechnology researchers to create predictive analytics models and eventually allow them to understand the most effective ways of achieving their desired goals and objectives. Big data, AI, virtual reality, data visualization, and data security are among the common technologies used in biotech laboratories. Tableau helped Novozymes cut the reporting times by more than 90%. It also assists in strategic decision-making within the company's departments such as sales, raw material purchase, +planning, and finance. In addition, Tableau allows Novozymes' sales force in sharing key insights with customers, thereby building relationships and enhancing revenue performance.
AstraZeneca, plc, a British-Swedish multinational pharmaceutical and biotechnology company, uses data and technology to minimize the time to discovery and delivery of potential new medicines. The company has data science and AI capabilities embedded in its R&D departments, which allows scientists to push the boundaries of science to deliver life-changing medicines. They apply AI throughout the discovery and development process, from target identification to clinical trials, to uncover new insights guiding the drug discovery and development process.
South & Central America Smart Life Sciences Manufacturing Market Overview
The smart life sciences manufacturing market in South America is segmented into Brazil, Argentina, and the rest of South America. The region is expected to develop moderately over the period owing to the positive influence of North American countries. South America is expected to have regulatory policies for the use and approval of medical devices, pharmaceuticals, and other life science products. The medical device market in Brazil is governed by the Brazilian Health Regulatory Agency, ANVISA. The ANVISA came up with a new resolution, RDC 687/2022, to grant or renew the Brazilian Good Manufacturing Practice (BGMP) certification for medical devices and is in effect from June 01, 2022, annulling RDC 183/2017. RDC 183 was published in 2017 to modernize and accelerate the process of issuing GMP certificates. The Resolution RDC no. 687 was published on May 13, 2022, to simplify the documentation required for GMP certification. It brings down the technical requirements for the certification, which gives great momentum to the certification process. Furthermore, manufacturers from the US, Canada, and other neighboring countries are expanding into countries in South America, and the manufacturers are focused on setting the smart manufacturing facilities, which will help in the long run. In May 2022, Johnson & Johnson South America partnered with Microsoft for business transformation by embedding intelligent automation into the organization. The opportunity to reimagine work is significant and has the potential to empower and equip employees with new skills; capabilities; and the freedom to focus on fulfilling, engaging, and purpose-driven work. Therefore, all the above-mentioned factors are expected to accelerate the smart life sciences manufacturing market growth in South America in the coming years.
South & Central America Smart Life Sciences Manufacturing Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Smart Life Sciences Manufacturing Market Segmentation
The South & Central America smart life sciences manufacturing market is segmented into technology, component, application, and country.
Based on component, the South & Central America smart life sciences manufacturing market is segmented into solutions and services. The solution segment held a larger share of the South & Central America smart life sciences manufacturing market in 2023.
Based on technology segment is categorized into AR/VR Systems, Internet of things (IOT), Artificial Intelligence (AI), Cybersecurity, Big Data, and others. The Internet of things segment held a largest share of the South & Central America smart life sciences manufacturing market in 2023. Further, the cybersecurity segment is categorized into IT cybersecurity and OT cybersecurity.
Based on Application, the South & Central America smart life sciences manufacturing market is segmented into pharma, bio-pharma, and medical devices. The pharma segment held the largest share of the South & Central America smart life sciences manufacturing market in 2023.
Based on country, the South & Central America smart life sciences manufacturing market is segmented into Argentina, Brazil, and the Rest of South & Central America. Brazil dominated the South & Central America smart life sciences manufacturing market in 2023.
ABB Ltd, Bosch Rexroth AG, Emerson Electric Co, Fortinet Inc, General Electric Co, Honeywell International Inc, International Business Machines Corp, Rockwell Automation Inc, Siemens AG, and Sophos Ltd are some of the leading companies operating in the South & Central America smart life sciences manufacturing market.